loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 213051 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Novo Nordisk

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NOVO (3)

    filter

    01 TABLET;ORAL (3)

    filter

    01 RX (3)

    filter

    01 RYBELSUS (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SEMAGLUTIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    14MG
    2019-09-20
    213051
    RYBELSUS
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SEMAGLUTIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    3MG
    2019-09-20
    213051
    RYBELSUS
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SEMAGLUTIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    7MG
    2019-09-20
    213051
    RYBELSUS
    RX
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 213051

    Looking for FDA Orange Book APPLICATION 213051 3

    19

    Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is SEMAGLUTIDE, with a corresponding application number 213051.

    Regulatory Information RX

    With a dosage strength 14MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug Yes

    Approved since 2019-09-20

    18

    Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is SEMAGLUTIDE, with a corresponding application number 213051.

    Regulatory Information RX

    With a dosage strength 3MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug Yes

    Approved since 2019-09-20

    17

    Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is SEMAGLUTIDE, with a corresponding application number 213051.

    Regulatory Information RX

    With a dosage strength 7MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug Yes

    Approved since 2019-09-20

    Post Enquiry
    POST ENQUIRY